{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:19:24Z","timestamp":1790054364551,"version":"4.0.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0190058","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T13:28:18Z","timestamp":1518614898000},"page":"e0190058","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection"],"prefix":"10.1371","volume":"13","author":[{"given":"Scott","family":"Balsitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volodymyr","family":"Gali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Chaniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Wichroski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Feulner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunling","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Granaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K.","family":"Loy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob A.","family":"Lesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Brockus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Menne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"Cockett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0315-5820","authenticated-orcid":true,"given":"Daniel J.","family":"Tenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013","volume":"388","author":"JD Stanaway","year":"2016","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coi.2015.06.016","article-title":"Host-virus interactions in hepatitis B virus infection","volume":"36","author":"LG Guidotti","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrgastro.2011.33","article-title":"Hepatitis B therapy","volume":"8","author":"H Kwon","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/hep.27323","article-title":"Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections","volume":"61","author":"B Rehermann","year":"2015","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cgh.2013.01.026","article-title":"Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency","volume":"11","author":"DK Wong","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2013.01.006","article-title":"Chronic hepatitis B: what should be the goal for new therapies?","volume":"98","author":"TM Block","year":"2013","journal-title":"Antiviral Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial","volume":"365","author":"HL Janssen","year":"2005","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1002\/hep.22956","article-title":"Benefits and risks of interferon therapy for hepatitis B","volume":"49","author":"R Perrillo","year":"2009","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"MK Maini","year":"2000","journal-title":"J Exp Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.181.3.1047","article-title":"The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis","volume":"181","author":"B Rehermann","year":"1995","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"R Thimme","year":"2003","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1128\/JVI.78.11.5707-5719.2004","article-title":"Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy","volume":"78","author":"GJ Webster","year":"2004","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"C Boni","year":"2007","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","article-title":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B","volume":"138","author":"P Fisicaro","year":"2010","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1053\/j.gastro.2012.08.041","article-title":"Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV","volume":"143","author":"P Fisicaro","year":"2012","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e105703","DOI":"10.1371\/journal.pone.0105703","article-title":"Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules","volume":"9","author":"B Raziorrouh","year":"2014","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00011-010-0233-1","article-title":"Intrahepatic levels of PD-1\/PD-L correlate with liver inflammation in chronic hepatitis B","volume":"60","author":"J Chen","year":"2011","journal-title":"Inflamm Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/hep.23173","article-title":"Chronically inflamed livers up-regulate expression of inhibitory B7 family members","volume":"50","author":"R Kassel","year":"2009","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.3748\/wjg.v17.i28.3322","article-title":"Immunostaining of PD-1\/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma","volume":"17","author":"BJ Wang","year":"2011","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1499-3872(13)60061-2","article-title":"Programmed death 1 and programmed death ligand 1 expressions in patients with chronic hepatitis B","volume":"12","author":"WJ Zhang","year":"2013","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"JR Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e63818","DOI":"10.1371\/journal.pone.0063818","article-title":"A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection","volume":"8","author":"D Gardiner","year":"2013","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.25730","article-title":"Transcriptomic analysis of the woodchuck model of chronic hepatitis B","volume":"56","author":"SP Fletcher","year":"2012","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e1003856","DOI":"10.1371\/journal.ppat.1003856","article-title":"Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection","volume":"10","author":"J Liu","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e26196","DOI":"10.1371\/journal.pone.0026196","article-title":"The expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infection","volume":"6","author":"E Zhang","year":"2011","journal-title":"PLoS One"},{"key":"ref26","unstructured":"Balsitis S, Matthew Healy, Paul Kayne, Vishal Patel, Volodymyr Gali, Karla Henning, Vangipuram S Rangan, Chris M. Thompson, Virginie Lafont, Melissa Hill-Drzewi, Hua Fang, Alan Korman, Daniel Tenney, and Stephen Mason (Manuscript submitted) A woodchuck IgG monoclonal antibody for evaluation of Hepatitis B cure strategies in the woodchuck hepatitis virus model."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.4049\/jimmunol.181.9.6664","article-title":"Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions","volume":"181","author":"L Baudino","year":"2008","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/74704","article-title":"Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets","volume":"6","author":"RA Clynes","year":"2000","journal-title":"Nat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.49.7.2720-2728.2005","article-title":"Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection","volume":"49","author":"S Menne","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/vim.1993.6.161","article-title":"New enzyme immunoassays for the serologic detection of woodchuck hepatitis virus infection","volume":"6","author":"PJ Cote","year":"1993","journal-title":"Viral Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jhep.2014.12.026","article-title":"Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B","volume":"62","author":"S Menne","year":"2015","journal-title":"J Hepatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"DL Barber","year":"2006","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"SL Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.gastro.2012.06.009","article-title":"Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B","volume":"143","author":"PT Kennedy","year":"2012","journal-title":"Gastroenterology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3748\/wjg.v16.i5.618","article-title":"Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells","volume":"16","author":"XS Liang","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1128\/JVI.02384-08","article-title":"Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12","volume":"83","author":"J Crettaz","year":"2009","journal-title":"J Virol"},{"key":"ref37","article-title":"HBV-specific and global T-cell dysfunction in chronic hepatitis B","author":"JJ Park","year":"2015","journal-title":"Gastroenterology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/hep.24473","article-title":"Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: a review","volume":"54","author":"YF Liaw","year":"2011","journal-title":"Hepatology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/hep.27731","article-title":"The royal wedding in chronic hepatitis B: The haves and the have-nots for the combination of pegylated interferon and nucleos(t)ide therapy","volume":"61","author":"P Lampertico","year":"2015","journal-title":"Hepatology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1086\/324003","article-title":"Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection","volume":"184","author":"RJ Colonno","year":"2001","journal-title":"J Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e39179","DOI":"10.1371\/journal.pone.0039179","article-title":"PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model","volume":"7","author":"HT Tzeng","year":"2012","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2015.11.001","article-title":"Combination therapy including CpG oligodeoxynucleotides and entecavir induces early viral response and enhanced inhibition of viral replication in a woodchuck model of chronic hepadnaviral infection","volume":"125","author":"Z Meng","year":"2016","journal-title":"Antiviral Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer","volume":"373","author":"H Borghaei","year":"2015","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1470-2045(15)00083-2","article-title":"Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial","volume":"16","author":"A Ribas","year":"2015","journal-title":"Lancet Oncol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1101\/gr.165985.113","article-title":"Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival","volume":"24","author":"SD Brown","year":"2014","journal-title":"Genome Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nm.3773","article-title":"High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma","volume":"21","author":"C Linnemann","year":"2015","journal-title":"Nat Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"A Snyder","year":"2014","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma","volume":"373","author":"J Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrd4591","article-title":"Combination cancer immunotherapy and new immunomodulatory targets","volume":"14","author":"KM Mahoney","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"10614","DOI":"10.1128\/JVI.00691-07","article-title":"Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein","volume":"81","author":"S Menne","year":"2007","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues","volume":"143","author":"C Boni","year":"2012","journal-title":"Gastroenterology"},{"key":"ref52","article-title":"Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination","author":"D Zhu","year":"2016","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1172\/JCI83339","article-title":"In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection","volume":"126","author":"X Zhang","year":"2016","journal-title":"J Clin Invest"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0190058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:48:04Z","timestamp":1540032484000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0190058"}},"subtitle":[],"editor":[{"given":"Isabelle","family":"Chemin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0190058","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,14]]}}}